Monday, March 27, 2017

Rethinking a Cancer Drug Target

Acute lymphoblastic leukemia is one of the cancer types for which MELK-inhibitors are being tested.WIKIMEDIA, JAMES GRELLIERA protein thought to be essential for cancer cells may not be so essential after all, according to a study published today (March 24) in eLife. Researchers at Cold...

Read full post here:
https://skpsoft.com/science/rethinking-a-cancer-drug-target/

No comments:

Post a Comment